IBJNews

Alzheimer’s targeted in $45M government study grant

Back to TopCommentsE-mailPrintBookmark and Share

The U.S. government renewed its commitment to preventing and treating Alzheimer’s disease, and has turned its focus to drugs that target the amyloid that builds up in patient’s brains with $45 million in new research funding.

The bulk of the money, or $33.2 million, will help fund a prevention trial of an experimental, as-yet unnamed anti-amyloid medicine for healthy older adults with a genetic predisposition to Alzheimer’s.

Another $1.5 million will go to an existing study of drugs from Roche Holding AG, MorphoSys AG and Indianapolis-based Eli Lilly and Co. to see whether they can ward off the disease in people who inherited genes that predestine them to get an early-onset form.

The pharmaceutical industry’s track record with drugs designed to remove the amyloid that accumulates between the brain’s nerve cells in people with Alzheimer’s has been poor. The latest efforts funded by the National Institutes of Health are designed to move in on the disease earlier, focusing on high-risk people who haven’t yet developed signs of Alzheimer’s.

“We know that Alzheimer’s-related brain changes take place years, even decades, before symptoms appear,” said Richard Hodes, director of the NIH’s National Institute on Aging, in a prepared statement. “That really may be the optimal window for drugs that delay progression or prevent the disease altogether.”

The U.S. government’s research funding has been hit by federal spending cuts brought on by sequestration, the automatic, across-the-board reductions triggered in March when lawmakers failed to agree on the nation’s budget. NIH Director Francis Collins provided $40 million of the $45 million from his own office, with the remainder coming from the NIA.

“We are determined, even in a time of constrained fiscal resources, to capitalize on exciting scientific opportunities to advance understanding of Alzheimer’s biology and find effective therapies as quickly as possible,” Collins said in a prepared statement.

The need is urgent. More than 5 million Americans are suffering with Alzheimer’s disease, and the number is expected to triple by 2050. There are no effective remedies to slow or treat the disease itself, while existing drugs ease symptoms for several months. The cost of caring for those patients tops $109 billion annually, more than both heart disease and cancer.

The NIH didn’t restrict its funding only to anti-amyloid drugs or patients who don’t yet have symptoms. The agency allocated $2.4 million for an early trial of allopregnanolone, a natural brain steroid that promotes the development of new brain cells and improves cognitive function in animal tests. The 12- week study will look at increasing doses of the treatment for patients with mild cognitive impairment and Alzheimer’s disease.

The remainder of the money will go to researchers working to better understand the complex networks that go awry in Alzheimer’s disease, potential targets for treatment and other genetic mutations that may make people more susceptible to it.

The drugs being evaluated in people that are genetically predisposed to early-onset Alzheimer’s include gantenerumab from Roche, based in Basel, Switzerland, and MorphoSys, of Martinsried, Germany, and solanezumab from Lilly.
 

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. If what you stated is true, then this article is entirely inaccurate. "State sells bonds" is same as "State borrows money". Supposedly the company will "pay for them". But since we are paying the company, we are still paying for this road with borrowed money, even though the state has $2 billion in the bank.

  2. Andrew hit the nail on the head. AMTRAK provides terrible service and that is why the state has found a contractor to improve the service. More trips, on-time performance, better times, cleanliness and adequate or better restrooms. WI-FI and food service will also be provided. Transit from outlying areas will also be provided. I wouldn't take it the way it is but with the above services and marketing of the service,ridership will improve and more folks will explore Indy and may even want to move here.

  3. They could take the property using eminent domain and save money by not paying the church or building a soccer field and a new driveway. Ctrwd has monthly meetings open to all customers of the district. The meetings are listed and if the customers really cared that much they would show. Ctrwd works hard in every way they can to make sure the customer is put first. Overflows damage the surrounding environment and cost a lot of money every year. There have been many upgrades done through the years to help not send flow to Carmel. Even with the upgrades ctrwd cannot always keep up. I understand how a storage tank could be an eye sore, but has anyone thought to look at other lift stations or storage tanks. Most lift stations are right in the middle of neighborhoods. Some close to schools and soccer fields, and some right in back yards, or at least next to a back yard. We all have to work together to come up with a proper solution. The proposed solution by ctrwd is the best one offered so far.

  4. Fox has comments from several people that seem to have some inside information. I would refer to their website. Changed my whole opionion of this story.

  5. This place is great! I'm piggy backing and saying the Cobb salad is great. But the ribs are awesome. $6.49 for ribs and 2 sides?! They're delicious. If you work downtown, head over there.

ADVERTISEMENT